ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

Pathological cardiac hypertrophy is an independent risk factor for heart failure and is considered a target for the treatment of heart failure. However, the mechanisms underlying pathological cardiac hypertrophy remain largely unknown. We aimed to investigate the role of angiopoietin-like protein 8...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Lin, Wei, Jiarui, Zhang, Yue, Wang, Ziyuan, Tang, Junming, Tang, Jian, Gao, Yujiu, Zhang, Xiaoqiao, Li, Yifan, Liu, Yantong, Ma, Shinan, Guo, Xingrong, Zhang, Qiufang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293964/
https://www.ncbi.nlm.nih.gov/pubmed/35851270
http://dx.doi.org/10.1038/s41419-022-05029-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293964/
https://www.ncbi.nlm.nih.gov/pubmed/35851270
http://dx.doi.org/10.1038/s41419-022-05029-8

Ejemplares similares